Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 100.
304. lappuse
... accurately about 250 milligrams of protamine and dissolve it in about 100 milliliters of approxi- mately tenth - normal hydrochloric acid . Heat to boiling and add 5 milli- liters of barium chloride test solution . Digest on a steam ...
... accurately about 250 milligrams of protamine and dissolve it in about 100 milliliters of approxi- mately tenth - normal hydrochloric acid . Heat to boiling and add 5 milli- liters of barium chloride test solution . Digest on a steam ...
305. lappuse
... accurately rep- resentative of the mixture which will constitute the finished batch ; in a quantity containing approximately 10,000 U.S.P. units of insulin . ( 4 ) If the batch is to be protamine zinc insulin suspension or isophane in ...
... accurately rep- resentative of the mixture which will constitute the finished batch ; in a quantity containing approximately 10,000 U.S.P. units of insulin . ( 4 ) If the batch is to be protamine zinc insulin suspension or isophane in ...
378. lappuse
... accurately weigh about 300 milligrams of the sample into a dry titrating vessel . If the maximum mois- ture limit is less than 1 percent , accu- rately weigh 1 to 2 grams of the sam- ple . Proceed as directed in paragraph ( e ) ( 1 ) or ...
... accurately weigh about 300 milligrams of the sample into a dry titrating vessel . If the maximum mois- ture limit is less than 1 percent , accu- rately weigh 1 to 2 grams of the sam- ple . Proceed as directed in paragraph ( e ) ( 1 ) or ...
390. lappuse
... Accurately weigh 20 to 30 milligrams of tetra- cycline hydrochloride working stand- ard into a suitable - sized volumetric flask . Dissolve and dilute to volume with water . Further dilute an accu- rately measured portion with distilled ...
... Accurately weigh 20 to 30 milligrams of tetra- cycline hydrochloride working stand- ard into a suitable - sized volumetric flask . Dissolve and dilute to volume with water . Further dilute an accu- rately measured portion with distilled ...
391. lappuse
... accurately measured portion of the filtrate with sufficient buffer solution , described in paragraph ( c ) ( 5 ) ( i ) of this section , to obtain a concentration of 0.01 to 0.03 milligram of cephradine per milliliter ( estimated ) ...
... accurately measured portion of the filtrate with sufficient buffer solution , described in paragraph ( c ) ( 5 ) ( i ) of this section , to obtain a concentration of 0.01 to 0.03 milligram of cephradine per milliliter ( estimated ) ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning